Retinal Damage in COVID-19 Patients: A Potential Indicator of Disease Severity
A cross-sectional study published in ‘Scientific Reports’ explores the impact of COVID-19 on the retina, suggesting that retinal damage may serve as a biomarker for the disease’s severity. The study examined retinal tissue and microvascular integrity in COVID-19 patients, revealing notable findings:
- Study Design and Participants: The study involved 20 COVID-19 patients (13 with mild symptoms and 7 severe) and 11 healthy controls. Participants were examined using Spectral-Domain Optical Coherence Tomography (SD-OCT) and Optical Coherence Tomography Angiography (OCTA) to assess retinal thickness, volume, and vessel density.
- Key Findings:
- Reduced Retinal Volume in Severe Cases: The retinal volume was significantly decreased in the outer 3mm of the macula in severe COVID-19 cases compared to mild cases and controls.
- Lower Total Retinal Vessel Density: The severe COVID-19 group exhibited a significantly lower total retinal vessel density compared to both the normal and mild COVID-19 groups. This decrease was particularly evident in the intermediate and deep capillary plexuses.
- Potential Biomarker of COVID-19 Severity: The results suggest that retinal tissue and microvascular loss may be indicative of COVID-19 severity. The study emphasizes that further monitoring of the retina in COVID-19-recovered patients could enhance understanding of the disease’s long-term sequelae.
- Clinical Implications: The decrease in retinal volume and vessel density in recovered COVID-19 patients, particularly those with severe cases, may not cause significant visual symptoms. However, it could be a biomarker for severe COVID-19, long COVID, or COVID-19-related damage to the brain and other organs. The study advocates for close monitoring and surveillance of recovered COVID-19 patients using OCT angiography, a non-invasive technique, to assess for long-term sequelae affecting the retina.
In conclusion, this study highlights the potential of retinal imaging as a valuable tool for assessing the severity of COVID-19 and its long-term impacts, offering new avenues for understanding and managing the disease’s complications.